Home Cart 0 Sign in  
X

[ CAS No. 1002535-21-8 ] {[proInfo.proName]}

,{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]}
3d Animation Molecule Structure of 1002535-21-8
Chemical Structure| 1002535-21-8
Chemical Structure| 1002535-21-8
Structure of 1002535-21-8 * Storage: {[proInfo.prStorage]}
Cart0 Add to My Favorites Add to My Favorites Bulk Inquiry Inquiry Add To Cart

Quality Control of [ 1002535-21-8 ]

Related Doc. of [ 1002535-21-8 ]

Alternatived Products of [ 1002535-21-8 ]

Product Details of [ 1002535-21-8 ]

CAS No. :1002535-21-8 MDL No. :MFCD06739075
Formula : C10H8N2O2 Boiling Point : -
Linear Structure Formula :- InChI Key :BXSUQWZHUHROLP-UHFFFAOYSA-N
M.W : 188.18 Pubchem ID :7174253
Synonyms :

Calculated chemistry of [ 1002535-21-8 ]

Physicochemical Properties

Num. heavy atoms : 14
Num. arom. heavy atoms : 11
Fraction Csp3 : 0.0
Num. rotatable bonds : 2
Num. H-bond acceptors : 3.0
Num. H-bond donors : 2.0
Molar Refractivity : 50.98
TPSA : 65.98 Ų

Pharmacokinetics

GI absorption : High
BBB permeant : Yes
P-gp substrate : No
CYP1A2 inhibitor : No
CYP2C19 inhibitor : No
CYP2C9 inhibitor : No
CYP2D6 inhibitor : No
CYP3A4 inhibitor : No
Log Kp (skin permeation) : -6.48 cm/s

Lipophilicity

Log Po/w (iLOGP) : 0.79
Log Po/w (XLOGP3) : 1.37
Log Po/w (WLOGP) : 1.77
Log Po/w (MLOGP) : 1.03
Log Po/w (SILICOS-IT) : 1.92
Consensus Log Po/w : 1.38

Druglikeness

Lipinski : 0.0
Ghose : None
Veber : 0.0
Egan : 0.0
Muegge : 1.0
Bioavailability Score : 0.85

Water Solubility

Log S (ESOL) : -2.32
Solubility : 0.902 mg/ml ; 0.00479 mol/l
Class : Soluble
Log S (Ali) : -2.36
Solubility : 0.824 mg/ml ; 0.00438 mol/l
Class : Soluble
Log S (SILICOS-IT) : -3.13
Solubility : 0.14 mg/ml ; 0.000745 mol/l
Class : Soluble

Medicinal Chemistry

PAINS : 0.0 alert
Brenk : 0.0 alert
Leadlikeness : 1.0
Synthetic accessibility : 1.86

Safety of [ 1002535-21-8 ]

Signal Word:Warning Class:N/A
Precautionary Statements:P264-P270-P301+P312-P330 UN#:N/A
Hazard Statements:H302 Packing Group:N/A
GHS Pictogram:

Application In Synthesis of [ 1002535-21-8 ]

* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.

  • Downstream synthetic route of [ 1002535-21-8 ]

[ 1002535-21-8 ] Synthesis Path-Downstream   1~7

  • 1
  • [ 25487-66-5 ]
  • [ 575452-22-1 ]
  • 3-(1-H-pyrazole-4-yl)benzoic acid [ No CAS ]
  • 2
  • [ 1002535-21-8 ]
  • [ 1922099-67-9 ]
  • [ 1922098-80-3 ]
YieldReaction ConditionsOperation in experiment
67% With dmap; 1-ethyl-(3-(3-dimethylamino)propyl)-carbodiimide hydrochloride In dichloromethane for 4h; Inert atmosphere; 31 Example 31: 1-(3-(1H-Pyrazol-4-yl)benzoyl)-N-(4-chlorophenyl)piperidine-3- carboxamide [00184] To a solution of carboxylic acid (0.047g, 0.25 mmole), DMAP (6 mg, 0.05 mmole) and piperidine derivative (0.06 g, 0.25 mmole) in DCM (3 mL) was added EDC (0.053 g, 0.28 mmole). The reaction mixture was stuffed under N2 for 4h. TLC indicated disappearance of the starting materials. The reaction mixture was extracted with saturated NaHCO3 (2 mL), 10% KHSO4 (1 mL) and water (2 x 2 mL). The solution was dried(NaSO4) and the solvent was removed under reduced pressure to give the product. The crude compound was purified by column chromatography eluting with 60 - 100% EtOAc/hexanes over 500 mL. Fractions were pooled after checking TLC. The solvent was removed under reduced pressure to give the title compound (0.069g, 67%) in pure form. ‘H NMR (400 MHz, CDC13, 56 °C) ö 9.07, 7.82, 7.64- 7.54, 7.49, 7.40, 7.27 - 7.19, 4.19 - 3.27, 2.68, 2.25, 1.95 & 1.71 - 1.43.
  • 3
  • [ 1002535-21-8 ]
  • [ 1922099-99-7 ]
  • [ 1922099-00-0 ]
YieldReaction ConditionsOperation in experiment
15% With dmap; 1-ethyl-(3-(3-dimethylamino)propyl)-carbodiimide hydrochloride; N-ethyl-N,N-diisopropylamine In tetrahydrofuran at 20℃; 51 Example 51: (3-(1H-pyrazol-4-yl)phenyl)(5-((4-chlorophenoxy)methyl)-3,3- difluoropiperidin-1-yl)methanone [00226] To a solution of 5-((4-chlorophenoxy)methyl)-3,3-difluoropiperidine (48 mg, 0.18 mmol) in THF (2 ml) was added 3-(1H-pyrazol-4-yl)benzoic acid (34 mg, 0.18 mmol), N-(3- dimethylaminopropyl)-N ‘-ethylcarbodiimide hydrochloride (53 mg, 0.28 mmol), N,Ndiisopropylethylamine (0.096 ml, 0.55 mmol), and 4-(dimethylamino)pyridine (4.5 mg, 0.037 mmol). The reaction stuffed at room temperature overnight. The reaction was diluted with ethyl acetate and washed with saturated sodium carbonate solution and brine. The organic layer was dried over magnesium sulfate, filtered, and concentrated. The crude residue was purified by column chromatography eluting with 0-5% methanol in dichloromethane to afford the title compound as a white amorphous solid (12 mg, yield 15%). ‘H NMR (400 MHz, CDC13, 55 °C) ö 10.39, 7.84, 7.56, 7.41, 7.27, 7.22, 7.67, 4.38, 4.25, 3.91, 3.40, 3.08, 2.45, 2.35, 1.99.
  • 6
  • [ 1002535-21-8 ]
  • [ 2227428-66-0 ]
  • [ 2227427-13-4 ]
YieldReaction ConditionsOperation in experiment
With N-ethyl-N,N-diisopropylamine; HATU In N,N-dimethyl-formamide at 20℃; for 4h; Final coupling: compounds 11, 20-29 General procedure: (S)-2-amino-N-(1-cyanocyclopropyl)-3-(pyridin-3-yl)propanamide (1 Eq.) acid (1 Eq.) and HATU (1.2 Eq.) were dissolved in DMF (0.145 M). DIPEA (4 Eq.) was added dropwise at room temperature and mixture stirred for 4H. The mixture was charged on a Si-CO3 cartridge (2 g) and eluted with MeOH. Volatiles were removed and crude purified by preparative Rp HPLC (MeCN/Water + 0.1% TFA).
  • 7
  • [ 1002535-21-8 ]
  • [ CAS Unavailable ]
  • [ CAS Unavailable ]
YieldReaction ConditionsOperation in experiment
Stage #1: indium(III) chloride With sodium tetrahydroborate In water at -1℃; Stage #2: 3-(1-H-pyrazole-4-yl)benzoic acid In water at -1℃; for 38.5h; Sonication; 2.1-2.2 Add 64ml of polyvinyl alcohol aqueous solution (concentration 0.1g/ml, of which polyethylene is 0.145mol),Add 3.75ml indium trichloride aqueous solution (concentration 0.8g/ml,Among them, 0.016mol of indium), stir at -1°C for 1.5h; keep stirring,To the above solution was added 37.344g of freshly prepared NaBH4 aqueous solution (concentration 9wt%,Among them, NaBH 40.09 mol) to form PVA-In nanosol;2) Disperse 3.952g/0.021mol 3-(1H-pyrazol-4-yl)benzoic acid in 39.517ml water, sonicate (frequency 1750Hz) for 33h, and then add it to the PVA-In nanosol prepared in step 1). Continue to stir at -1°C for 5.5 hours, then centrifuge, wash with deionized water 4 times,Dry at 100°C for 4 hours, then transfer to a roasting furnace and roast at 410°C for 4 hours,An In-MOF catalyst is obtained. (The mass fraction of indium in the catalyst is about 17.985wt%)
Same Skeleton Products
Historical Records

Related Functional Groups of
[ 1002535-21-8 ]

Aryls

Chemical Structure| 1017794-47-6

[ 1017794-47-6 ]

4-(1H-Pyrazol-4-yl)benzoic acid

Similarity: 1.00

Chemical Structure| 1187931-83-4

[ 1187931-83-4 ]

3-(1H-Pyrazol-4-yl)benzoic acid hydrochloride

Similarity: 0.98

Chemical Structure| 1017794-45-4

[ 1017794-45-4 ]

4-(1H-Pyrazol-4-yl)benzaldehyde

Similarity: 0.86

Chemical Structure| 1017794-46-5

[ 1017794-46-5 ]

3-(1H-Pyrazol-4-yl)benzaldehyde

Similarity: 0.86

Chemical Structure| 185252-69-1

[ 185252-69-1 ]

4-(3,5-Dimethyl-1H-pyrazol-4-yl)benzoic acid

Similarity: 0.81

Carboxylic Acids

Chemical Structure| 1017794-47-6

[ 1017794-47-6 ]

4-(1H-Pyrazol-4-yl)benzoic acid

Similarity: 1.00

Chemical Structure| 1187931-83-4

[ 1187931-83-4 ]

3-(1H-Pyrazol-4-yl)benzoic acid hydrochloride

Similarity: 0.98

Chemical Structure| 1183147-84-3

[ 1183147-84-3 ]

3-(1-Methyl-1H-pyrazol-4-yl)benzoic acid

Similarity: 0.81

Chemical Structure| 185252-69-1

[ 185252-69-1 ]

4-(3,5-Dimethyl-1H-pyrazol-4-yl)benzoic acid

Similarity: 0.81

Chemical Structure| 199678-06-3

[ 199678-06-3 ]

4-(1-Methyl-1H-pyrazol-4-yl)benzoic acid

Similarity: 0.81

Related Parent Nucleus of
[ 1002535-21-8 ]

Pyrazoles

Chemical Structure| 1017794-47-6

[ 1017794-47-6 ]

4-(1H-Pyrazol-4-yl)benzoic acid

Similarity: 1.00

Chemical Structure| 1187931-83-4

[ 1187931-83-4 ]

3-(1H-Pyrazol-4-yl)benzoic acid hydrochloride

Similarity: 0.98

Chemical Structure| 1017794-45-4

[ 1017794-45-4 ]

4-(1H-Pyrazol-4-yl)benzaldehyde

Similarity: 0.86

Chemical Structure| 1017794-46-5

[ 1017794-46-5 ]

3-(1H-Pyrazol-4-yl)benzaldehyde

Similarity: 0.86

Chemical Structure| 185252-69-1

[ 185252-69-1 ]

4-(3,5-Dimethyl-1H-pyrazol-4-yl)benzoic acid

Similarity: 0.81